Skip to main content
Sanket Dhruva, MD, Cardiology, San Francisco, CA, San Francisco VA Medical Center

SanketDhruvaMDMHS

Cardiology San Francisco, CA

Assistant Professor of Medicine

Dr. Dhruva is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Dhruva's full profile

Already have an account?

Education & Training

  • University of California Davis Health
    University of California Davis HealthFellowship, Cardiovascular Disease, 2012 - 2015
  • University of California (San Francisco)
    University of California (San Francisco)Residency, Internal Medicine, 2009 - 2012
  • University of California San Francisco School of Medicine
    University of California San Francisco School of MedicineClass of 2009

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 2010 - 2024
  • CT State Medical License
    CT State Medical License 2015 - 2018
  • American Board of Internal Medicine Cardiovascular Disease

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Trends in Within-Class Changes in US Average Wholesale Prices for Brand-Name Medications for Common Conditions from 2015 to 2020  
    Sanket Dhruva, MD, JAMA Network Open
  • Intravascular Microaxial Left Ventricular Assist Device vs Intra-Aortic Balloon Pump for Cardiogenic Shock—Reply  
    Sanket S Dhruva, Nihar R Desai, JAMA
  • Trends in Use of Transcatheter Aortic Valve Replacement by Age  
    Rita F Redberg, Art Sedrakyan, Sanket S Dhruva, JAMA

Authored Content

  • Intravascular Microaxial Left Ventricular Assist Device vs Intra-Aortic Balloon Pump for Cardiogenic Shock—ReplyJuly 2020

Press Mentions

  • Do All Those Postmarket Device Modifications Add up to Patient Harm?
    Do All Those Postmarket Device Modifications Add up to Patient Harm?April 12th, 2023
  • F.D.A.’s Drug Industry Fees Fuel Concerns Over Influence
    F.D.A.’s Drug Industry Fees Fuel Concerns Over InfluenceSeptember 15th, 2022
  • The Latest on Breakthrough Devices, Crowdsourced Monkeypox Support, & VA’s Stumble on Digital Divide
    The Latest on Breakthrough Devices, Crowdsourced Monkeypox Support, & VA’s Stumble on Digital DivideAugust 11th, 2022
  • Join now to see all

Professional Memberships

Hospital Affiliations